ACS Omega
(May 2020)
N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria
- Mark Laws,
- Charlotte Hind,
- Andrea Favaron,
- Shirin Jamshidi,
- Bonnie Evans,
- Melanie Clifford,
- J. Mark Sutton,
- Khondaker Miraz Rahman
Affiliations
- Mark Laws
- Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.
- Charlotte Hind
- Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.
- Andrea Favaron
- Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.
- Shirin Jamshidi
- Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.
- Bonnie Evans
- Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.
- Melanie Clifford
- Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.
- J. Mark Sutton
- Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.
- Khondaker Miraz Rahman
- Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.
- DOI
-
https://doi.org/10.1021/acsomega.9b03910
- Journal volume & issue
-
Vol. 5,
no. 21
pp.
11923
– 11934
WeChat QR code